Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

How Much Does Lung Cancer Treatment Cost in Jordan?

The cost of Lung Cancer Treatment in Jordan generally ranges between USD 10000 - USD 25000, depending on the type and stage of cancer, the treatment approach required (surgery, chemotherapy, targeted therapy, immunotherapy, or radiation), hospital quality, oncologist expertise, diagnostic investigations, and the overall duration of care.

Additional expenses such as PET-CT scans, biopsies, genetic testing, anaesthesia, supportive medications, ICU care, and follow-up consultations may also influence the total treatment cost.

Factors Influencing the Cost of Lung Cancer Treatment

Type of Lung Cancer: Costs differ between NSCLC and SCLC, with NSCLC often requiring surgery or targeted therapy and SCLC needing intensive chemo or radiation.
Stage of Cancer: Early stages cost less due to limited treatment, while advanced stages require multimodal therapies that increase expenses.
Treatment Approach: Costs vary based on surgery, chemotherapy, targeted therapy, immunotherapy, and radiation techniques used.
Diagnostic & Staging Tests: PET-CT, CT/MRI scans, biopsies, and molecular profiling increase overall diagnosis-related costs.
Hospital Standards: Premium cancer centres in Amman with advanced equipment and oncology units generally charge higher fees.
Surgeon & Oncologist Expertise: Experienced thoracic surgeons and oncologists may have higher professional charges due to specialised skills.
Duration & Complexity of Care: Multiple chemo cycles, radiation sessions, long-term follow-up, and supportive therapy increase treatment costs.
ICU & Hospital Stay: ICU care, hospitalisation, postoperative imaging, and respiratory physiotherapy add to surgical treatment expenses.
Supportive & Palliative Care: Pain control, palliative radiotherapy, lung drainage, infection management, and transfusions contribute to additional costs.
Medications & Follow-Up: Ongoing medications, surveillance scans, and follow-up oncologist visits impact long-term treatment expenditure.

What's included in your Lung Cancer Treatment quote?

Lung Cancer Treatment

Personalised treatment plan including surgery, chemotherapy, radiotherapy, immunotherapy, or targeted therapy as recommended

Oncology team consultation

Pre-treatment evaluation, treatment planning, and post-treatment follow-up consultations

Hospital stay & supportive care

Inpatient care, nursing support, pain management, and recovery monitoring

Follow-up monitoring

Imaging, laboratory tests, treatment response assessment, and routine follow-up visits

Visa & medical-visa invite letter

Airport pickup & transfers

Get Itemized Quote FREE

Cost of Lung Cancer Treatment in Major Cities of Jordan

City	Cost (USD)
Amman	$10,000 – $25,000	Explore More

Lung Cancer Treatment - Jordan Vs the World

$0 - $0

$0 - $0

$4k - $20k

$8k - $12k

$8k - $22k

$8k - $20k

$10k - $50k

$10k - $26k

$12k - $100k

$17k - $27k

$18k - $42k

$20k - $100k

$20k - $28k

$30k - $60k

$30k - $100k

Find the Right Destination for Your Lung Cancer Treatment Journey

Jordan

$10,000 – $25,000

JCI-accredited hospitals - Popular Middle East hub - Arabic & English support - Easy regional access

Switzerland

$60,000 – $120,000

Premium private hospitals - Exceptional quality standards - Personalized patient care - Multilingual healthcare services

Singapore

$30,000 – $100,000

World-renowned hospitals - Exceptional quality standards - Highly efficient healthcare - English-speaking environment

Spain

$20,000 – $100,000

Renowned university hospitals - Strong healthcare system - JCI-accredited facilities - Longer public waiting lists

Author

Nimra Haseeb

MSc Biochemistry

4 Years of Experience

Last Reviewed - June 2026

Miss Nimra Haseeb is a medical researcher and a scientific content writer. She holds a Bachelor’s degree in Biotechnology and a Master’s in Biochemistry from Integral University, Lucknow. With strong experience in healthcare research, she specializes in secondary research, clinical data analysis, and evidence-based medical writing. Her work focuses on transforming complex scientific and medical information into clear, accurate, and reliable healthcare content for patients and healthcare audiences. She is also experienced in interpreting medical studies and healthcare trends to deliver well-researched and informative content that supports better health awareness and decision-making.

Reviewer

Dr Prateek Varshney

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.

Lung cancer is a disease characterized by the uncontrolled division of cells in the lungs. Normally, cells divide and replicate as part of their normal function. However, sometimes mutations occur, causing cells to divide uncontrollably. These damaged cells form masses, or tumors, which can eventually impair the function of organs.

It refers to cancers that originate in the lungs, generally in the airways (bronchi or bronchioles) or the small air sacs (alveoli). Cancers that originate in other parts of the body and spread to the lungs are usually referred to by the location where they began. In such cases, your doctor may describe this condition as metastatic cancer to the lungs.

Moreover, It is the third most common Cancer in the USA and is caused by harmful cells present in the lungs that grow unchecked. Different types of treatment are Chemotherapy, Immunotherapy, Radiation, and Targeted drugs. Advancements in the treatment options are causing a significant decline in lung cancer deaths.

Types

Following are different kinds of Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for over 80% of cases. Adenocarcinoma and squamous cell carcinoma are two popular kinds of non-small cell lung cancer. Sarcomatoid and adenosquamous carcinomas are less prevalent.
Small cell lung cancer (SCLC) grows more rapidly and is more challenging to treat than NSCLC. It is often detected as a relatively small lung tumor that has already spread to other parts of the body. Specific types of SCLC include small cell carcinoma (also known as oat cell carcinoma) and combined small cell carcinoma.

Other Types of Cancer in the Lungs

Other cancers can originate in or around the lungs, such as

lymphomas (cancer in the lymph nodes)
sarcomas (cancer in the bones or soft tissue)
pleural mesothelioma (cancer in the lining of the lungs)

These cancers are treated differently and are usually not classified as lung cancer.

Lung Cancer Stages

It is important to determine the stage of lung cancer by finding out how far the cancer has spread, before initiating treatment of lung cancer.
The following are the four lung cancer stages of NSCLC:

Stage 1 lung cancer: Cancer is restricted to the lung
Stage 2 lung cancer: Cancer has spread to the nearby lymph nodes
Stage 3 lung cancer: (3a) Cancer is in the lung and the lymph nodes located on the same side (3b) Cancer is in the lung and has spread to lymph nodes on the opposite side
Stage 4 lung cancer: Cancer has spread to both the lungs and other organs and surrounding tissues

Frequently Asked Questions

Lung cancer treatment involves a combination of medical and surgical approaches used to remove, shrink, or control cancer in the lungs. Treatment depends on the type of cancer (NSCLC or SCLC), tumour size, stage of disease, and the patient's overall health. Management may include surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, or a combination of these to eliminate cancer cells and improve survival.

Lung cancer treatment is recommended when a patient:

Has been diagnosed with Non-Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Shows persistent symptoms such as chronic cough, blood in sputum, chest pain, shortness of breath, or unexplained weight loss

Has tumours been detected through CT, PET-CT, or biopsy

Has early-stage lung cancer that is suitable for surgical removal

Requires systemic therapy for advanced or metastatic disease

Shows abnormal findings on imaging or lung function tests

Treatment is highly personalised and depends on cancer stage, tumour genetics, and patient fitness.

Lung cancer treatment involves one or more of the following major approaches:Surgery

Lobectomy - Removal of an entire lobe of the lung

Segmentectomy/Wedge Resection - Removal of small tumour segments

Pneumonectomy - Removal of the whole lung

VATS/Robotic Surgery - Minimally invasive approaches for faster recovery.

Surgery is mainly used for early-stage NSCLC.Chemotherapy

Uses cancer-killing drugs in cycles

Often used for SCLC, advanced NSCLC, or after surgery (adjuvant therapy)

Radiation Therapy

Uses focused radiation (IMRT, 3D-CRT, SBRT)

Suitable for patients who cannot undergo surgery or require combined therapy

Targeted Therapy

For tumours with specific mutations (EGFR, ALK, ROS1, BRAF)

Works by blocking cancer cell growth signals

Immunotherapy

Drugs are used to strengthen the immune system’s attack on cancer

Used for advanced or metastatic cancer

Most patients require a multidisciplinary treatment plan tailored to tumour biology and disease spread.

Possible risks include:

Fatigue, nausea, or hair loss from chemotherapy

Skin irritation or difficulty swallowing from radiation

Infection or bleeding after surgery

Shortness of breath or reduced lung function

Immune-related side effects from immunotherapy

Rare but serious complications like pneumonia or blood clots

Complications are minimised with experienced specialists and supportive care.

Leading centres for lung cancer treatment in Jordan include:

Arab Medical Center, Amman

These hospitals offer advanced oncology services, PET-CT imaging, thoracic surgery units, targeted therapy options, and multidisciplinary tumour boards to ensure comprehensive care.

Recovery varies by treatment type:

Surgery: 4-8 weeks for initial recovery

Chemotherapy cycles: 3-6 months

Radiation therapy: 4-7 weeks

Targeted therapy/Immunotherapy: Ongoing, long-term management

Patients often continue follow-up scans and medical visits every 3–6 months to monitor progress.

Additional expenses may include:

Diagnostic tests (CT, PET-CT, MRI, biopsy)

Tumour genetic profiling (EGFR, ALK, PD-L1)

Anaesthesia and surgical equipment charges

Medications (anti-nausea, antibiotics, inhalers)

Hospital stay, ICU monitoring (if required)

Follow-up imaging and consultations

Supportive care (oxygen therapy, physiotherapy, nutrition support)

These help ensure accurate diagnosis, safe treatment, and effective long-term management.

Amman is the top destination due to:

Specialist oncology hospitals

Advanced diagnostic and radiotherapy technologies

Skilled thoracic surgeons and medical oncologists

Comprehensive palliative and supportive care services

Jordan is preferred for lung cancer therapy because of:

Internationally recognised oncology experts

Advanced radiotherapy and thoracic surgery infrastructure

Affordable treatment compared to Western countries

High-quality patient care standards

Access to targeted and immunotherapy drugs

Strong multidisciplinary cancer care

The success rate depends on cancer type and stage:

Early-stage NSCLC (surgery): 70-90% success

Locally advanced disease: Improved outcomes with combined therapy

Advanced/metastatic cases: Meaningful survival improvement with targeted and immunotherapy

Jordan’s leading cancer centres report high survival rates when treatment is timely and personalised.

Welcome To MediGence